Galactosed and Reduction-Responsive Nanoparticles Assembled from Trimethylchitosan-Camptothecin Conjugates for Enhanced Hepatocellular Carcinoma Therapy
The targeted delivery of drugs to tumor cells and prevention of premature release before reaching the target is one of the key challenges to developing nanomedicines. In this paper, galactose decorated trimethyl chitosan (GT)-camptothecin (CPT) prodrug nanoparticles (GT-ss-CPT NPs) were prepared fro...
Saved in:
Main Authors: | Chen Fu (Author), Jingcan Qin (Author), Xinlong Liu (Author), Fei Kong (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma
by: Yu Xia, et al.
Published: (2019) -
Nanoparticles from Gantrez-based conjugates for the oral delivery of camptothecin
by: Judit Huarte, et al.
Published: (2021) -
Self-Assembled Disulfide Bond Bearing Paclitaxel-Camptothecin Prodrug Nanoparticle for Lung Cancer Therapy
by: Jingyan Gao, et al.
Published: (2020) -
Synthesis and appraisal of dalbergin-loaded PLGA nanoparticles modified with galactose against hepatocellular carcinoma: In-vitro, pharmacokinetic, and in-silico studies
by: Anurag Kumar Gautam, et al.
Published: (2022) -
Preparation, characterization and in vivo evaluation of alginate-coated chitosan and trimethylchitosan nanoparticles loaded with PR8 influenza virus for nasal immunization
by: Jafar Mosafer, et al.
Published: (2019)